Multifocal VEP and OCT in optic neuritis: A topographical study of the structure - Function relationship

Documenta Ophthalmologica

Volumn 118, Issue 2, 2009, Pages 129-137

  Klistorner, Alexander ^a   Arvind, H ^a   Nguyen, T ^b   Garrick, R ^c   Paine, M ^b   Graham, S ^a   O'Day, J ^b   Yiannikas, C ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Axonal loss; Multifocal visual evoked potentials (mfVEP); Multiple sclerosis; Optic neuritis; Optical coherence tomography (OCT)

Indexed keywords

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEVICE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; IMAGING; MALE; OPTIC NERVE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; RETINA; THICKNESS; VISUAL FIELD;

ADULT; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; OPTIC NERVE; OPTIC NEURITIS; RETINAL NEURONS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL FIELDS;

EID: 61849138946     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-008-9147-4     Document Type: Article

References (62)

1. Tintore M, Rovira A, Rio J et al (2005) Is optic neuritis more benign than other first attacks in multiple sclerosis. Ann Neurol 57:210-215. doi: 10.1002/ana.20363
2. Beck RW, Trobe JD, Moke PS et al (2003) High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: Experience of the optic neuritis treatment trial. Arch Ophthalmol 121:944-949. doi: 10.1001/archopht.121.7.944
3. Ghezzi A, Martinelli V, Torri V et al (1999) Long-term follow-up of isolated optic neuritis: The risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol 246:770-775. doi: 10.1007/s004150050453
4. Rodriguez M, Siva A, Cross SA et al (1995) Optic neuritis: A population-based study in Olmsted County, Minnesota. Neurology 45:244-250
5. Lassmann H (2005) Pathology of neurons in multiple sclerosis. In: SG Waxman (ed) Multiple sclerosis as a neuronal disease. Elsevier, Amsterdam, pp 153-164
6. Trapp BD, Peterson J, Ransohoff RM et al (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285. doi: 10.1056/NEJM199801293380502
7. Kornek B, Storch MK, Weissert R et al (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol 157:267-276
8. Youl BD, Turano G, Miller DH et al (1991) The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114:2437-2450. doi: 10.1093/brain/ 114.6.2437
9. Kallenbach K, Fredericksen JL (2007) Optical coherence tomography in optic neuritis and multiple sclerosis: A review. Eur J Neurol 14:841-849. doi: 10.1111/j.1468-1331.2007.01736.x
10. Sergott RC, Frohman EM, Glanzman R, Al-Sabbagh A (2007) Optical coherence tomography in multiple sclerosis: Expert panel consensus. J Neurol Sci 263:3-14
11. Trip A, Schlottmann PG, Jones SJ et al (2006) Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 31:286-293. doi: 10.1016/j.neuroimage.2005.11.051
12. Quigley HA, Davis EB, Anderson DR (1977) Descending optic nerve degeneration in primates. Invest Ophthalmol Vis Sci 16:841-849
13. Trip A, Schlottmann PG, Jones SJ et al (2005) Retinal nerve fiber layer loss and visual disfunction in optic neuritis. Ann Neurol 58:383-391. doi: 10.1002/ana.20575
14. Costello F, Coupland S, Zackon D et al (2005) Measurement of axon loss with optical coherence tomography in patients with optic neuritis. North American Neuro-Opthalmology society meeting proceedings, p 188
15. Parisi V, Manni G, Spadaro M et al (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 40:2520-2527
16. Sergott RC (2005) Optical coherence tomography: Measuring in vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Curr Opin Ophthalmol 16:346-350. doi: 10.1097/ 01.icu.0000188705.67815.0e
17. Fisher JB, Jacobs DA, Markowitz CE et al (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113:324-332
18. Henderson A, Trip A, Schlottmann PG et al (2008) An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain Pathol 131:277-287
19. Nuver MR (2006) Evoked potentials. In: Cook SD (ed) Handbook on multiple sclerosis. Taylor and Francis, New York, pp 243-269
20. Jones SJ, Brusa A (2003) Neurophysiological evidence for long-term repair of MS lesions: Implications for axon protection. J Neurol Sci 206:193-198. doi: 10.1016/S0022-510x(02)00428-8
21. Daniel P, Whittridge D (1961) The representation of the visual field on the cerebral cortex in monkeys. J Physiol 159:203-221
22. Riggs LA, Wooden BR (1972) Electrical measures and psychophysical data on human vision. In: Jamison D, Hurvich LM (eds) Handbook of sensory physiology, vol 7/4. Springer-Verlag, New York, pp 690-731
23. Yiannikas C, Walsh JC (1983) The variation of the pattern shift visual evoked response with the size of the stimulus field. Electroencephalogr Clin Neurophysiol 55:427-435. doi: 10.1016/0013-4694(83)90131-1
24. Fraser C, Klistorner A, Graham SL et al (2006) Multifocal visual evoked potential latency analysis: Predicting progression to multiple sclerosis. Arch Neurol 63:846-850
25. Baseler HA, Sutter EE, Klein SA, Carney T (1994) The topography of visual evoked response properties across the visual field. Electroencephalogr Clin Neurophysiol 90:65-81. doi: 10.1016/ 0013-4694(94)90114-7
26. Klistorner AI, Graham SL, Grigg JR, Billson FA (1998) Multifocal topographic visual evoked potential: Improving objective detection of local visual field defects. Invest Ophthalmol Vis Sci 39:937-950
27. Hood DC, Ohri N, Bo Yang E et al (2005) Determining abnormal latencies of multifocal visual evoked potentials: A monocular analysis. Doc Ophthalmol 109:189-199. doi: 10.1007/s10633-004-5512-0
28. Fraser C, Klistorner A, Graham SL et al (2006) Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis. Ophthalmology 113:315-323
29. Hood DC (2000) Assessing retinal function with the multifocal technique. Prog Retin Eye Res 19:607-646. doi: 10.1016/S1350-9462(00)00013-6
30. Graham SL, Klistorner A, Goldberg I (2005) Clinical application of objective perimetry using multifocal VEP in glaucoma practice. Arch Ophthalmol 123:729-739. doi: 10.1001/archopht.123.6.729
31. Hood DC, Thienprasiddhi P, Greenstein VC et al (2004) Detecting early to mild glaucomatous damage: A comparison of the multifocal VEP and automated perimetry. Invest Ophthalmol Vis Sci 45:492-498. doi: 10.1167/ iovs.03-0602
32. Hood DC, Zhang X, Greenstein VC et al (2000) An interocular comparison of the multifocal VEP: A possible technique for detecting local damage to the optic nerve. Invest Ophthalmol Vis Sci 41:1580-1587
33. Klistorner A, Fraser C, Garrick R et al (2007) Correlation between full-field and multifocal VEPs in optic neuritis. Doc Ophthalmol 116:19-27. doi: 10.1007/s10633-007-9072-y
34. Ruseckaite R, Maddess T, Danta G et al (2005) Sparse multifocal stimuli for the detection of multiple sclerosis. Ann Neurol 57:904-913. doi: 10.1002/ana.20504
35. Klistorner A, Graham SL, Fraser C et al (2007) Electrophysiological evidence for heterogeneity of lesions in optic neuritis. Invest Ophthalmol Vis Sci 48:4549-4556. doi: 10.1167/iovs.07-0381
36. Hood DC, Odel JG, Zhang X (2000) Tracking the recovery of local optic nerve function after optic neuritis: A multifocal VEP study. Invest Ophthalmol Vis Sci 41:4032-4038
37. Noval S, Contreras I, Rebolleda G, Munoz-Negrete FJ (2006) Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scand 84:790-794. doi: 10.1111/ j.1600-0420.2006.00724.x
38. Frohman EM, Costello F, Stuve O et al (2008) Modeling axonal degeneration within the anterior visual system. Ann Neurol 65:26-35
39. McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of the multiple sclerosis. Ann Neurol 50:121-127. doi: 10.1002/ana.1032
40. Graham SL, Klistorner AI, Grigg JR, Billson FA (2000) Objective VEP perimetry in glaucoma: Asymmetry analysis to identify early deficits. J Glaucoma 9:10-19
41. Klistorner A, Graham SL (2001) Electroencephalogram-based scaling of multifocal visual evoked potentials: Effect on intersubject amplitude variability. Invest Ophthalmol Vis Sci 42:2145-2152
42. Goldberg I, Graham SL, Klistorner A (2002) Multifocal objective perimetry in the detection of glaucomatous field loss. Am J Ophthalmol 133:29-39. doi: 10.1016/S0002-9394(01)01294-6
43. Klistorner AI, Graham SL, Grigg JR, Billson FA (1998) Electrode position and the multi-focal visual-evoked potential: Role in objective visual field assessment. Aust NZ J Ophthalmol 26:91-94. doi: 10.1111/ j.1442-9071.1998.tb01386.x
44. Graham SL, Klistorner A (1999) The diagnostic significance of the multifocal pattern visual evoked potential in glaucoma. Curr Opin Ophthalmol 10:140-146. doi: 10.1097/00055735-199904000-00011
45. Garway-Heath DF, Poinoosawmy D, Fitzke F, Hitchings RA (2000) Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology 107:1809-1815. doi: 10.1016/S0161-6420(00)00284-0
46. Balachandran C, Graham SL, Klistorner A, Goldberg I (2006) Comparison of objective diagnostic tests in glaucoma: Heidelberg retinal tomography and multifocal visual evoked potentials. J Glaucoma 15:110-116. doi: 10.1097/00061198-200604000-00006
47. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A et al (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 66:1488-1494. doi: 10.1212/01.wnl.0000260612.51849.ed
48. Alamouti B, Funk J (2003) Retinal thickness decreases with age: An OCT study. Br J Ophthalmol 87:899-901. doi: 10.1136/bjo.87.7.899
49. Paunescu LA, Schuman JS, Price LL et al (2004) Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry. Invest Ophthalmol Vis Sci 40:2520-2527
50. Hickman SJ, Toosy AT, Jones SJ et al (2004) A serial MRI study following optic nerve mean area in acute optic neuritis. Brain Pathol 127:2498-2505
51. Toosy AT, Hickman SJ, Mizszkiel KA et al (2005) Adaptive cortical plasticity in higher visual areas after optic neuritis. Ann Neurol 57:622-633. doi: 10.1002/ana.20448
52. Smith KJ, Waxman SG (2005) The conduction properties of demyelinated and remyelinated axons. In: Waxman SG (ed) Multiple sclerosis as neuronal disease. Elsevier Academic Press, Amsterdam, pp 85-100
53. Kutzelnigg A, Lucchinetti CF, Stadelmann C et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain Pathol 128:2705-2712
54. Filippi M, Rocca M (2005) MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 252(Suppl):v16-v24. doi: 10.1007/s00415-005-5004-5
55. Lassmann H (2007) New concepts on progressive multiple sclerosis. Cur Neurol Neurosci Rep 7:239-244
56. Parisi V, Manni G, Centofanti M et al (2001) Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients. Ophthalmology 108:905-912. doi: 10.1016/S0161-6420(00)00644-8
57. Costello F, Coupland S, Hodge W et al (2006) Quantifying axonal loss after optic neuritis with optical coherent tomography. Ann Neurol 59:963-969. doi: 10.1002/ana.20851
58. Kerrison JB, Flynn T, Green WR (1994) Retinal pathologic changes in multiple sclerosis. Retina 14:445-451. doi: 10.1097/ 00006982-199414050-00010
59. Evangelou N, Konz D, Esiri MM et al (2001) Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124:1813-1820. doi: 10.1093/brain/124.9.1813
60. Budenz DL, Chang RT, Huang X et al (2005) Reproducibility of retinal nerve fiber thickness measurements using the stratus OCT in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 46:2440-2443. doi: 10.1167/ iovs.04-1174
61. Klistorner A, Graham SL (2006) Interest variability of mfVEP amplitude: reducing its effect on the interpretation of sequential tests. Doc Ophthalmol 111:159-167. doi: 10.1007/s10633-005-5363-3
62. Klistorner A, Graham SL (2000) Objective perimetry in glaucoma. Ophthalmology 107:2283-2299